ALAN BUFFENSTEIN: Open Payments
NPI 1639278104 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 13 payments from 6 companies in 2025. Trend: 2023 $457 · 2024 $1,161 · 2025 $567
Food & beverage: $460Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $198 |
| E.R. Squibb & Sons, L.L.C. | 1 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $107 |
| AstraZeneca Pharmaceuticals LP | 1 | $104 |
| Alkermes, Inc. | 1 | $22 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
Products named: INVEGA SUSTENNA, COBENFY, WAINUA, ARISTADA, NUPLAZID.
Industry payments across HI — which companies pay providers there.
